Impact of both donor and recipient strains on cardiac allograft survival after blockade of the CD40-CD154 costimulatory pathway

Transplantation

Volumn 74, Issue 5, 2002, Pages 740-743

  Van Maurik, Andre ^a   Wood, Kathryn J ^a   Jones, Nick D ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY;

ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; GENOTYPE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; MORPHOMETRICS; MOUSE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; STRAIN DIFFERENCE; SURVIVAL RATE; T LYMPHOCYTE;

EID: 0037106250     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200209150-00026     Document Type: Article

References (10)

1. Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996;381(6581):434.
2. Kirk AD, Harlan DM, Armstrong NN, et al. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci U S A 1997;94(16):8789.
3. + T cells play a critical role in costimulation blockade-resistant allograft rejection. J Clin Invest 1999;104:1715.
4. + T cells can trigger allograft rejection. J Immunol 2000;165(2):1111.
5. Williams MA, Trambley J, Ha J, et al. Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts. J Immunol 2000;165:6849.
6. Ensminger SM, Spriewald BM, Sorensen HV, et al. Critical role for IL-4 in the development of transplant arteriosclerosis in the absence of CD40-CD154 costimulation. J Immunol 2001;167:532.
7. + T cell tolerance and linked suppression. J Immunol 1999;163:4805.
8. Ferrari-Lacraz S, Zheng XX, Kim YS, et al. An antagonist IL-15/Fc protein prevents costimulation blockade-resistant rejection. J Immunol 2001; 167:3478.
9. Jones ND, Turvey SE, van Maurik A, et al. Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection. J Immunol 2001;166(4):2824.
10. + T cells. Transplantation 2000;70(6):955.